4.7 Article

Increasing Incidence of Post-Kala-Azar Dermal Leishmaniasis in a Population-Based Study in Bangladesh

Journal

CLINICAL INFECTIOUS DISEASES
Volume 50, Issue 1, Pages 73-76

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1086/648727

Keywords

-

Funding

  1. US Agency for International Development-Centers for Disease Control and Prevention interagency [GHN-T-00-06-00001-00]
  2. National Institutes of Health [F32GM085945]
  3. NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM085945] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Post-kala-azar dermal leishmaniasis (PKDL) occurs after kala-azar treatment and acts as a durable infection reservoir. On the basis of active case finding among 22,699 respondents, 813 (3.6%) had had kala-azar since 2002, of whom 79 (9.7%) developed PKDL. Eight additional patients with PKDL had no history of kala-azar. Annual kala-azar incidence peaked at 85 cases per 10,000 person-years in 2004 and fell to 46 cases per 10,000 person-years in 2007, but PKDL incidence rose from 1 case per 10,000 person-years in 2002-2004 to 21 cases per 10,000 person-years in 2007. The rising PKDL incidence threatens the regional visceral leishmaniasis elimination initiative and underscores the urgent need for more effective PKDL diagnosis and treatment.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available